Sex differences in gut microbiota in patients with major depressive disorder

Código QR

Sex differences in gut microbiota in patients with major depressive disorder

Jian-jun Chen,1–4 Peng Zheng,2,3 Yi-yun Liu,2,3 Xiao-gang Zhong,2,3 Hai-yang Wang,2,3 Yu-jie Guo,2,3 Peng Xie2,3 1Institute of Life Sciences, 2Department of Neurology, First Affiliated Hospital, 3Institute of Neuroscience, 4Joint International Research Laboratory of Reproduction and Devel...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chen JJ, Zheng P, Liu YY, Zhong XG, Wang HY, Guo YJ, Xie P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	major depressive disorder MDD gut microbiota biomarker Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/f16af7f401124063a74889ed0747c541
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Gut Microbiota-Derived Inflammation-Related Serum Metabolites as Potential Biomarkers for Major Depressive Disorder
por: Bai S, et al.
Publicado: (2021)

EFFECT OF SINGLE DOSE OF KETAMINE IN PATIENTS OF MAJOR DEPRESSIVE DISORDER-A PAKISTANI PERSPECTIVE
por: Muhammad Siddique Kakar, et al.
Publicado: (2020)

The Complex Molecular Picture of Gut and Oral Microbiota–Brain-Depression System: What We Know and What We Need to Know
por: Catia Scassellati, et al.
Publicado: (2021)

Psychophysiological Effects of <i>Lactobacillus plantarum</i> PS128 in Patients with Major Depressive Disorder: A Preliminary 8-Week Open Trial
por: Hui-Mei Chen, et al.
Publicado: (2021)

Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder
por: Huang YC, et al.
Publicado: (2018)

Neuronal connectivity in major depressive disorder: a systematic review
por: Helm K, et al.
Publicado: (2018)

Impact of Expression and Genetic Variation of microRNA-34b/c on Cognitive Dysfunction in Patients with Major Depressive Disorder
por: Sun N, et al.
Publicado: (2020)

Evaluation of cognitive impairment in patients with major depressive disorder in remission
por: Mustafa Ali, et al.
Publicado: (2021)

MicroRNAs as Critical Biomarkers of Major Depressive Disorder: A Comprehensive Perspective
por: Miguel A. Ortega, et al.
Publicado: (2021)

Left Dorsolateral Prefrontal Cortex Glx/tCr Predicts Efficacy of High Frequency 4- to 6-Week rTMS Treatment and Is Associated With Symptom Improvement in Adults With Major Depressive Disorder: Findings From a Pilot Study
por: Pallab Bhattacharyya, et al.
Publicado: (2021)

Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics
por: Gui SW, et al.
Publicado: (2018)

Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan
por: Watanabe Y, et al.
Publicado: (2018)

Pioglitazone could induce remission in major depression: a meta-analysis
por: Colle R, et al.
Publicado: (2016)

Magnetic Resonance Hippocampal Subfield Volumetric Analysis for Differentiating among Healthy Older Adults and Older Adults with Mild Cognitive Impairment or Major Depressive Disorder
por: Doonyaporn Wongsawaeng, et al.
Publicado: (2021)

Altered Fecal Microbiota Signatures in Patients With Anxiety and Depression in the Gastrointestinal Cancer Screening: A Case-Control Study
por: Juan Zhu, et al.
Publicado: (2021)

Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression
por: Ni P, et al.
Publicado: (2021)

Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation
por: Bai S, et al.
Publicado: (2021)

Predictors of Major Depressive Disorder in Older People
por: Susana Sousa, et al.
Publicado: (2021)

Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Ning Li, et al.
Publicado: (2021)

Efficacy and Safety of tDCS and tACS in Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Factorial Placebo-Controlled Study Design
por: Huang Y, et al.
Publicado: (2021)

Reliability and Validity of THINC-it in Evaluating Cognitive Function of Patients with Bipolar Depression
por: Zhang W, et al.
Publicado: (2020)

Corrigendum: Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Ning Li, et al.
Publicado: (2021)

Modulatory interactions of resting-state brain functional connectivity in major depressive disorder
por: Tu Z, et al.
Publicado: (2018)

The Developmental and Translational Study on Biomarkers and Clinical Characteristics-based Diagnostic and Therapeutic Identification of Major Depressive Disorder: Study Protocol for a Multicenter Randomized Controlled Trial in China
por: Liu X, et al.
Publicado: (2020)

Gut Microbiota Regulates Depression-Like Behavior in Rats Through the Neuroendocrine-Immune-Mitochondrial Pathway
por: Liu S, et al.
Publicado: (2020)

Possible role of the gut microbiota in the pathogenesis of anorexia nervosa
por: Nobuyuki Sudo
Publicado: (2021)

Potential Genetic Overlap Between Insomnia and Sleep Symptoms in Major Depressive Disorder: A Polygenic Risk Score Analysis
por: Lindsay M. Melhuish Beaupre, et al.
Publicado: (2021)

Serum Exosome-Derived miR-139-5p as a Potential Biomarker for Major Depressive Disorder
por: Liang JQ, et al.
Publicado: (2020)

Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
por: F Kheirkhah, et al.
Publicado: (2010)

Identifying factors associated with the hospital readmission rate among patients with major depressive disorder
por: Sharareh Parami, et al.
Publicado: (2021)

Childhood Emotional Neglect Is Associated With Low Social Support in Chinese Patients With Major Depressive Disorder
por: Xuemei Qin, et al.
Publicado: (2021)

The impact of age of onset on amygdala intrinsic connectivity in major depression
por: Clark DL, et al.
Publicado: (2018)

Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
por: Xue-Qin Wang, et al.
Publicado: (2021)

Fecal Microbiota Transplantation Beneficially Regulates Intestinal Mucosal Autophagy and Alleviates Gut Barrier Injury
por: Saisai Cheng, et al.
Publicado: (2018)

Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
por: Hammer-Helmich L, et al.
Publicado: (2018)

Identification of Gene Co-Expression Modules and Core Genes Related to Immune Disorders in Major Depression Disorder
por: Zhang L, et al.
Publicado: (2021)

Neurostimulation Methods in the Treatment of Depression: A Comparison of rTMS, tDCS, and Venlafaxine Using a Pooled Analysis of Two Studies
por: Hejzlar M, et al.
Publicado: (2021)

The Profile and Function of Gut Microbiota in Diabetic Nephropathy
por: Chen W, et al.
Publicado: (2021)

Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder
por: Inoue T, et al.
Publicado: (2020)

Psychometric Properties of the Chinese Version of the Clinically Useful Depression Outcome Scale for Patients with Major Depressive Disorder
por: Ma HY, et al.
Publicado: (2021)